| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| CDMO原料药及中间体(元) | 174,015,984.58 | 405,658,643.85 | 231,001,664.79 | 263,079,986.81 | 184,687,726.64 |
| 仿制药原料药及中间体(元) | 992,215,272.43 | 2,004,740,643.32 | 1,066,156,907.91 | 2,350,005,129.09 | 1,269,211,569.45 |
| 制剂(元) | 97,029,467.17 | 105,029,678.06 | - | 33,968,396.04 | 10,152,917.11 |
| 其他(元) | 2,143,093.02 | 11,841,146.24 | - | 19,624,959.86 | 9,881,537.54 |
| 营业成本(元) | |||||
| CDMO原料药及中间体(元) | 83,665,196.30 | 175,887,793.15 | 95,488,745.04 | 126,128,264.77 | 93,943,391.38 |
| 仿制药原料药及中间体(元) | 689,545,055.10 | 1,314,915,624.44 | 698,554,921.84 | 1,823,618,080.41 | 952,438,279.23 |
| 制剂(元) | 42,348,144.29 | 39,024,240.62 | - | 13,860,372.65 | - |
| 其他(元) | 1,481,229.58 | 7,394,081.72 | - | 15,529,910.95 | - |
| 毛利(元) | |||||
| CDMO原料药及中间体(元) | 90,350,788.28 | 229,770,850.70 | 135,512,919.75 | 136,951,722.04 | 90,744,335.26 |
| 仿制药原料药及中间体(元) | 302,670,217.33 | 689,825,018.88 | 367,601,986.07 | 526,387,048.68 | 316,773,290.22 |
| 制剂(元) | 54,681,322.88 | 66,005,437.44 | - | 20,108,023.39 | - |
| 其他(元) | 661,863.44 | 4,447,064.52 | - | 4,095,048.91 | - |
| 毛利率(%) | |||||
| CDMO原料药及中间体(%) | 51.92 | 56.64 | 58.66 | 52.06 | 49.13 |
| 仿制药原料药及中间体(%) | 30.50 | 34.41 | 34.48 | 22.40 | 24.96 |
| 制剂(%) | 56.36 | 62.84 | - | 59.20 | - |
| 其他(%) | 30.88 | 37.56 | - | 20.87 | - |
| 收入构成(%) | |||||
| CDMO原料药及中间体(%) | 13.75 | 16.05 | 17.81 | 9.87 | 12.53 |
| 仿制药原料药及中间体(%) | 78.41 | 79.32 | 82.19 | 88.12 | 86.11 |
| 制剂(%) | 7.67 | 4.16 | - | 1.27 | 0.69 |
| 其他(%) | 0.17 | 0.47 | - | 0.74 | 0.67 |
| 毛利构成(%) | |||||
| CDMO原料药及中间体(%) | 20.15 | 23.21 | 26.93 | 19.92 | 22.27 |
| 仿制药原料药及中间体(%) | 67.51 | 69.68 | 73.07 | 76.56 | 77.73 |
| 制剂(%) | 12.20 | 6.67 | - | 2.92 | 0.00 |
| 其他(%) | 0.15 | 0.45 | - | 0.60 | 0.00 |